Comparison of the effectiveness of two doses of vitamin D3 in critically ill patients undergoing continuous renal replacement therapy - NephroD
MULTICENTER, RANDOMIZED CLINICAL TRIAL
We invite you to participate in the NephroD study, which aims to assess the effectiveness of supplementation (ability to normalize serum vitamin D levels) of two different doses of enteral vitamin D3, in patients in the intensive care unit undergoing continuous renal replacement therapy.
To start entering patient observation data, please log in.
BioStat® monitors the smooth progress of the study and data analysis.
Please direct any questions to the Organizer's office.
BioStat Sp. z o.o.
Kowalczyka 17, 44-206 Rybnik
phone: 530 714 118
email: [email protected]